In 320 treatment-naive patients with symptomatic persistent AF, first-line cryoballoon ablation cut atrial tachyarrhythmia recurrence during days 91–365 vs antiarrhythmic drugs (18.8% vs 44.4%; HR for drugs vs ablation 2.29) and improved AFEQT quality-of-life scores.
RCTn = 320
Ling et al. Cryoballoon ablation vs. antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: the multicentre randomized CEPAF trial